Dr. Mohammed Qintar is a consultant in interventional and structural cardiology and a leading name in the treatment of heart valve disease and advanced cardiac interventions. He currently serves as a structural heart specialist at Hamad Heart Hospital in Doha, Qatar, where he offers patients the most advanced catheter-based therapies without traditional open surgery, and he serves as associate director of the training program there.
He previously served as director of the structural heart program and vice chief of the cardiology division at University of Michigan Health System Sparrow Hospital in the United States, and he is an associate professor at Michigan State University. Dr. Qintar holds American Board certifications in internal medicine, cardiology, and interventional cardiology, in addition to advanced echocardiography, after an advanced training path that included the Cleveland Clinic and some of the most respected heart centers in the United States, including Henry Ford Hospital and the Mid America Heart Institute in Kansas City, where he trained with one of the most renowned cardiologists in the United States — the physician who had performed the first transcatheter aortic valve replacement at that time.
He has extensive, advanced expertise in heart valve therapy, including transcatheter aortic valve replacement (TAVR), mitral transcatheter edge-to-edge repair (M-TEER), transcatheter treatment of tricuspid regurgitation, tricuspid valve replacement and repair for complex cases, and valve-in-valve techniques for failing bioprosthetic valves. He also has particular expertise in adult congenital heart interventions, including closure of atrial septal defects (ASD), patent foramen ovale (PFO), ventricular septal defects (VSD), and paravalvular leaks. In coronary artery disease, he has broad experience with coronary stenting, revascularization of chronic total occlusions (CTO), complex high-risk PCI, and mechanical circulatory support in cardiogenic shock.
Alongside his clinical work, he has led and participated as a principal investigator in numerous international clinical trials in heart valve disease, atrial fibrillation, and coronary artery disease, with research published in leading medical journals such as the Journal of the American College of Cardiology and Circulation. He has received several awards in recognition of his excellence in research and teaching, including best-teacher awards over multiple years. Dr. Qintar combines advanced American training, high technical precision, and a humane vision that places the patient at the heart of every treatment decision, delivering comprehensive, state-of-the-art care in structural heart disease and complex coronary artery disease.
